Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Mediclin stock price, quote, forecast and news

MED.DE
DE0006595101
659510

Price

2.30
Today +/-
-0.16
Today %
-6.72 %
P

Mediclin stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Mediclin stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Mediclin stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Mediclin stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Mediclin's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Mediclin Stock Price History

DateMediclin Price
9/16/20242.30 undefined
9/13/20242.46 undefined
9/12/20242.36 undefined
9/11/20242.42 undefined
9/10/20242.50 undefined
9/9/20242.50 undefined
9/6/20242.48 undefined
9/5/20242.50 undefined
9/4/20242.50 undefined
9/3/20242.52 undefined
9/2/20242.52 undefined
8/30/20242.52 undefined
8/29/20242.50 undefined
8/28/20242.54 undefined
8/27/20242.54 undefined
8/26/20242.50 undefined
8/23/20242.50 undefined
8/22/20242.50 undefined
8/21/20242.54 undefined
8/20/20242.48 undefined
8/19/20242.50 undefined

Mediclin Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Mediclin, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Mediclin from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Mediclin’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Mediclin. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Mediclin’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Mediclin’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Mediclin’s growth potential.

Mediclin Revenue, EBIT and net profit per share

DateMediclin RevenueMediclin EBITMediclin Net Income
2026e772.64 M undefined47.92 M undefined21.11 M undefined
2025e755.68 M undefined44.1 M undefined18.23 M undefined
2024e733.66 M undefined40.29 M undefined13.19 M undefined
2023766.75 M undefined18.72 M undefined-10.78 M undefined
2022722.32 M undefined19.52 M undefined9.44 M undefined
2021687.08 M undefined11.56 M undefined1.46 M undefined
2020670.99 M undefined150,730 undefined-9 M undefined
2019686.44 M undefined22.41 M undefined9.66 M undefined
2018654.95 M undefined15.06 M undefined7.72 M undefined
2017626.41 M undefined6.62 M undefined3.91 M undefined
2016589.45 M undefined24.02 M undefined16.55 M undefined
2015562.08 M undefined23.61 M undefined16.54 M undefined
2014544.97 M undefined15.56 M undefined8.5 M undefined
2013521.9 M undefined2.1 M undefined-2.6 M undefined
2012517.6 M undefined5.1 M undefined-1.4 M undefined
2011505.9 M undefined10.9 M undefined3 M undefined
2010497.4 M undefined16.9 M undefined10 M undefined
2009480.1 M undefined17 M undefined10.3 M undefined
2008466.1 M undefined15.8 M undefined7.1 M undefined
2007398.2 M undefined18.9 M undefined5.7 M undefined
2006387.4 M undefined16.7 M undefined9.5 M undefined
2005377.9 M undefined16.1 M undefined7.7 M undefined
2004372.3 M undefined-7.8 M undefined-13.6 M undefined

Mediclin Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
288317329387375372377387398466480497505517521544562589626654686670687722766733755772
-10.073.7917.63-3.10-0.801.342.652.8417.093.003.541.612.380.774.413.314.806.284.474.89-2.332.545.096.09-4.313.002.25
80.2181.7079.9480.1080.0080.3879.8479.3378.6477.2577.5077.8778.2278.5378.6980.5181.6781.4981.9581.8082.3683.2882.1081.5882.11---
231259263310300299301307313360372387395406410438459480513535565558564589629000
332715-6-9-71616181517161052152324615220111918404447
11.468.524.56-1.55-2.40-1.884.244.134.523.223.543.221.980.970.382.764.094.070.962.293.21-1.602.632.355.465.836.09
-858-13-16-13795710103-1-281616379-819-10131821
--162.5060.00-262.5023.08-18.75-153.8528.57-44.4440.0042.86--70.00-133.33100.00-500.00100.00--81.25133.3328.57-188.89-112.50800.00-211.11-230.0038.4616.67
21.231.831.831.831.831.830.331.931.832.747.547.547.547.547.547.547.547.547.547.547.547.547.547.547.5000
----------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Mediclin Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Mediclin is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                 
76106.392.646.828.418.22729.121.462.461.75246.8271729.3632.7245.6532.4438.6546.6105.62147.97136.26174.38
36.138.94747.937.239.349.246.752.75456.361.658.159.861.461.9767.3371.148493.1101.1476.3481.2188.4981.58
26.51.32.51.927.927.72.64.3310.12.13.932.12.63.434.853.443.798.118.8311.2516.3313.3112.71
1012.27.710.311.1124.54.74.65.86.56.56.87.16.56.366.156.277.297.468.089.348.518.877.3
4.43.27.17.15.76.23.24.67.32.321.51.61.34.21.710.931.241.341.211.341.3111.915.0823.86
153161.9156.9114110.3103.486.589.489134.6128.6125.5116.397.391.7102.83111.98127.73128.87148.53166203.86265.93262.01299.83
148.6148.6160.5217.2210.5203.6121.3120.6128.5145.6146.8150.3154.6161.6158.6155.54161.16161.61177.51194.56617.49572.04508.26543.94514.38
15.9160.70.70.700.30.30.30.40.10.10.12.32.31.770.770.070.070.070.110.090.070.070.07
0000000600600500500400300300200070.830.130000000
0.90.91.11.61.51.50.81.11.122.12.41.91.72.11.961.913.66.087.818.828.797.075.676.12
50.547.96160.555.451.346.84545.252.849.151.250.149.349.348.5948.4848.5748.8348.8349.2549.2549.8749.8716.69
10.20.70.70.71.512.911.45.37.46.66.55.57.18.54.765.045.477.2844.9556.0853.4350.0454.5643.43
216.9213.6224280.7268.8257.9182.1179181208.7205.2210.9212.5222.3221212.61217.44219.33239.76296.21731.75683.61615.31654.1580.68
369.9375.5380.9394.7379.1361.3268.6268.4270343.3333.8336.4328.8319.6312.7315.43329.43347.06368.63444.73897.75887.46881.24916.11880.5
                                                 
20.531.531.531.531.531.531.531.531.547.347.547.547.547.547.547.547.547.547.547.547.547.547.547.547.5
0000000000000000000000129.34129.340
-10.695103.882.962.949.355.866.972.7101.6109.8117.4118.1109.6104.9106.84121.99134.39138.03144.11143.49129.66135.78161.71148.42
00000-3,7000000000000000000-2071640
0000000000000000000000000
9.9126.5135.3114.494.477.187.398.4104.2148.9157.3164.9165.6157.1152.4154.34169.49181.89185.53191.61190.99177.16312.41338.71195.92
79.78.310.39.210.51112.411.914.614.815.214.620.521.113.0412.0212.9913.7217.117.611.3113.0214.512.63
00000000013.512.912.913.514.314.1000000026.6328.750
45.532.838.240.263.245.549.335.831.620.919.720.18.76.8933.4237.5735.5734.7550.0157.4179.25118.61106.17107.65
000000000500500400300000000000000
20327.337.123.4422.20.77.268.474.571.271.271.58.66.96.886.8510.5716.4920.8570.7880.7981.7750.1850.96
255.569.883.673.9114.458.26155.4111.9124119.1119.8108.650.251.153.3456.4459.1364.9687.97145.8171.35240.04199.59171.24
159064.881.950.784.491.383.222.621.411.46.89.66760.553.3346.7545.0337.4554.93441.36406.07358.18452.49428.86
0000001.41.21.11.41.82.42.83.33.80000000000
89.589.496.4120.4114.5136.328.828.328.447.644.242.442.142.245.254.9657.161.3480.96110.43119.85133.2126.6283.4684.37
104.5179.4161.2202.3165.2220.7121.5112.752.170.457.451.654.5112.5109.5108.29103.85106.37118.41165.36561.21539.27484.81535.95513.23
360249.2244.8276.2279.6278.9182.5168.1164194.4176.5171.4163.1162.7160.6161.63160.29165.5183.37253.33707.01710.62724.85735.54684.47
0.370.380.380.390.370.360.270.270.270.340.330.340.330.320.310.320.330.350.370.440.90.891.041.070.88
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Mediclin provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Mediclin's financial health and stability.

Assets

Mediclin's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Mediclin must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Mediclin after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Mediclin's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
9158-13-16-131616181516161042152324379-919
251515212122788121413161717181819202271777371
000000005000100000000000
-5515-1138-2012-11-1045-12-10-61-6-8-16-11-18423-48
0-127-8-521-18-5-12-8-4-5-12-5-2-3-4-41297732
0000000000554220111298810
000000000012101004543023
-1934291361117711243213151693230292027691188134
00000000-28-19-19-21-27-24-16-19-25-26-35-46-44-25-17-26
380-13-23-38-12-12-14-8-19-2-15-16-22-20-11-12-18-17-37-38-35-8-7-6
380-13-23-38-12-12-14-891735545768-18917919
000000000000000000000000
-335-100-15-16-12-6000-22-13-5-5-14-8-6-71-121-18-37-46-46
011500000403800700000000000
-3378-13-21-15-652014-15-70-14-8-6-80217-30-46-55-56
-2-51-4-305-10-1000000-1-14-2-9-8-8-10
0000000000-2-2-2000000-2-2000
2330-7-46-20-782-7361-10-6-18-913312-14636319-27
-19.3934.5729.8813.766.941117.537.53-17.264.8813.27-7.95-11.89-8.58-6.6812.154.983.75-15.67-18.4724.6692.5264.968.62
000000000000000000000000

Mediclin stock margins

The Mediclin margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Mediclin. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Mediclin.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Mediclin's sales revenue. A higher gross margin percentage indicates that the Mediclin retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Mediclin's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Mediclin's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Mediclin's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Mediclin. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Mediclin's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Mediclin Margin History

Mediclin Gross marginMediclin Profit marginMediclin EBIT marginMediclin Profit margin
2026e82.08 %6.2 %2.73 %
2025e82.08 %5.84 %2.41 %
2024e82.08 %5.49 %1.8 %
202382.08 %2.44 %-1.41 %
202281.62 %2.7 %1.31 %
202182.22 %1.68 %0.21 %
202083.21 %0.02 %-1.34 %
201982.38 %3.27 %1.41 %
201881.77 %2.3 %1.18 %
201782.02 %1.06 %0.62 %
201681.56 %4.08 %2.81 %
201581.66 %4.2 %2.94 %
201480.38 %2.86 %1.56 %
201378.73 %0.4 %-0.5 %
201278.54 %0.99 %-0.27 %
201178.18 %2.15 %0.59 %
201077.8 %3.4 %2.01 %
200977.61 %3.54 %2.15 %
200877.37 %3.39 %1.52 %
200778.8 %4.75 %1.43 %
200679.27 %4.31 %2.45 %
200579.86 %4.26 %2.04 %
200480.53 %-2.1 %-3.65 %

Mediclin Stock Sales Revenue, EBIT, Earnings per Share

The Mediclin earnings per share therefore indicates how much revenue Mediclin has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Mediclin earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Mediclin's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Mediclin’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Mediclin's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Mediclin Revenue, EBIT and net profit per share

DateMediclin Sales per ShareMediclin EBIT per shareMediclin Earnings per Share
2026e16.27 undefined0 undefined0.44 undefined
2025e15.91 undefined0 undefined0.38 undefined
2024e15.45 undefined0 undefined0.28 undefined
202316.14 undefined0.39 undefined-0.23 undefined
202215.21 undefined0.41 undefined0.2 undefined
202114.46 undefined0.24 undefined0.03 undefined
202014.13 undefined0 undefined-0.19 undefined
201914.45 undefined0.47 undefined0.2 undefined
201813.79 undefined0.32 undefined0.16 undefined
201713.19 undefined0.14 undefined0.08 undefined
201612.41 undefined0.51 undefined0.35 undefined
201511.83 undefined0.5 undefined0.35 undefined
201411.47 undefined0.33 undefined0.18 undefined
201310.99 undefined0.04 undefined-0.05 undefined
201210.9 undefined0.11 undefined-0.03 undefined
201110.65 undefined0.23 undefined0.06 undefined
201010.47 undefined0.36 undefined0.21 undefined
200910.11 undefined0.36 undefined0.22 undefined
200814.25 undefined0.48 undefined0.22 undefined
200712.52 undefined0.59 undefined0.18 undefined
200612.14 undefined0.52 undefined0.3 undefined
200512.47 undefined0.53 undefined0.25 undefined
200411.71 undefined-0.25 undefined-0.43 undefined

Mediclin business model

Mediclin AG is a German company specializing in the care and treatment of patients. It was founded in 1984 in Berlin and has since relocated its headquarters to Offenburg. Mediclin operates over 50 healthcare facilities throughout Germany, including hospitals, rehabilitation centers, nursing facilities, and medical care centers. The company employs approximately 10,000 employees and generated a revenue of 1.17 billion euros in 2020. Mediclin is one of the most popular companies on Eulerpool.com.

Mediclin SWOT Analysis

Strengths

Mediclin AG has a strong reputation in the healthcare industry due to its high-quality medical services and state-of-the-art facilities.

The company has a large network of hospitals and clinics, allowing it to serve a wide range of patients and offer diverse medical specialties.

Weaknesses

One weakness of Mediclin AG is its dependency on government contracts and reimbursements, which can be subject to changes in healthcare policies and regulations.

The company may face challenges in maintaining consistent revenue growth as healthcare costs continue to rise and potential budget constraints arise.

Opportunities

There is a growing demand for healthcare services, particularly in specialized areas such as geriatrics and mental health, which presents opportunities for Mediclin AG to expand its offerings.

The company can also explore partnerships and collaborations with research institutions or technology companies to enhance its medical technologies and treatments.

Threats

Increased competition within the healthcare industry poses a threat to Mediclin AG's market share and profitability.

Changes in healthcare regulations and policies, as well as potential economic downturns, can also pose threats to the company's financial stability.

Mediclin Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Mediclin historical P/E ratio, EBIT, and P/S ratio.

Mediclin shares outstanding

The number of shares was Mediclin in 2023 — This indicates how many shares 47.5 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Mediclin earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Mediclin's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Mediclin’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Mediclin's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Mediclin dividend history and estimates

In 2023, Mediclin paid a dividend amounting to 0 EUR. Dividend means that Mediclin distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Mediclin provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Mediclin’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Mediclin's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Mediclin Dividend History

DateMediclin Dividend
20190.05 undefined
20180.05 undefined
20110.05 undefined
20100.05 undefined
20090.05 undefined

Mediclin dividend payout ratio

In 2023, Mediclin had a payout ratio of 27.35%. The payout ratio indicates the percentage of the company's profits that Mediclin distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Mediclin represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Mediclin could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Mediclin's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Mediclin Payout Ratio History

DateMediclin Payout ratio
2026e27.22 %
2025e27.08 %
2024e27.23 %
202327.35 %
202226.66 %
202127.69 %
202027.7 %
201924.58 %
201830.78 %
201727.76 %
201627.91 %
201528.37 %
201429.74 %
201333.86 %
201246.23 %
201183.33 %
201023.81 %
200922.73 %
200846.23 %
200746.23 %
200646.23 %
200546.23 %
200446.23 %
Unfortunately, there are currently no price targets and forecasts available for Mediclin.

Mediclin latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20110.1 0.05  (-50.5 %)2011 Q4
9/30/20110.08 0.04  (-50.5 %)2011 Q3
6/30/20110.03 0.01  (-67 %)2011 Q2
12/31/20100.07 0.08  (13.15 %)2010 Q4
9/30/20100.12 0.1  (-17.49 %)2010 Q3
6/30/20100.06 0.06  (-0.99 %)2010 Q2
3/31/2010-0.04 -0.03  (25.74 %)2010 Q1
12/31/20090.02 0.06  (197.03 %)2009 Q4
9/30/20090.13 0.12  (-8.61 %)2009 Q3
6/30/20090.08 0.08  (-0.99 %)2009 Q2
1

Eulerpool ESG Scorecard© for the Mediclin stock

Eulerpool World ESG Rating (EESG©)

32/ 100

🌱 Environment

24

👫 Social

52

🏛️ Governance

20

Environment

Scope 1 - Direct Emissions
20,421
Scope 2 - Indirect emissions from purchased energy
6,674
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
27,095
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Mediclin list of shareholders

%
Name
Stocks
Change
Date
52.72970 % Asklepios Kliniken Verwaltungsgesellschaft mbH25,046,608012/7/2023
35.00420 % ERGO Versicherungsgruppe AG16,626,996012/7/2023
1.24168 % Dimensional Fund Advisors, L.P.589,797-4,1091/31/2024
0.87290 % Knoesel & Ronge Vermögensverwaltung GmbH & Co. KG414,628012/31/2023
0.44632 % TBF Global Asset Management GmbH212,000100,00012/31/2023
0.21053 % DZ PRIVATBANK S.A.100,00004/30/2023
0.16842 % Greiff capital management AG80,00009/30/2022
0.00372 % Russell Investments Limited1,76805/31/2023
0.00372 % Mercer Global Investments Management Ltd1,76802/29/2024
0 % VM Vermögens-Management GmbH0-100,00011/30/2023
1
2

Mediclin Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Muenchener Rueckversicher Stock
Muenchener Rueckversicher
SupplierCustomer0,730,37-0,20-0,07-0,230,09
1

Most common questions regarding Mediclin

What values and corporate philosophy does Mediclin represent?

Mediclin AG represents a set of core values and a corporate philosophy focused on providing high-quality healthcare services. With a strong emphasis on patient-centric care, Mediclin AG aims to prioritize the well-being and satisfaction of patients. The company strives to deliver excellent medical outcomes by continuously investing in cutting-edge technology and medical expertise. Medical professionalism, integrity, and ethical conduct are central to Mediclin AG's approach, ensuring that patients receive reliable and trustworthy healthcare services. By promoting collaboration among medical professionals and fostering a supportive environment, Mediclin AG aims to create a positive and healing experience for all patients.

In which countries and regions is Mediclin primarily present?

Mediclin AG is primarily present in Germany.

What significant milestones has the company Mediclin achieved?

Mediclin AG has achieved several significant milestones in its journey. With a strong focus on providing excellent healthcare services, the company has expanded its network and gained recognition in the industry. Mediclin AG has successfully established state-of-the-art medical facilities, attracting renowned doctors and specialists. Through strategic partnerships and acquisitions, Mediclin AG has enhanced its service offerings and geographical presence. The company's commitment to patient care, innovative treatments, and continuous improvement has earned it a reputable position in the healthcare sector. These milestones have propelled Mediclin AG towards further growth and success in delivering high-quality healthcare services to patients.

What is the history and background of the company Mediclin?

Mediclin AG is a renowned healthcare company based in Germany. With a rich history spanning several decades, Mediclin AG has established itself as a leading provider of medical services and rehabilitation facilities. The company focuses on offering high-quality patient care through a network of clinics, acute care hospitals, and outpatient facilities across the country. Mediclin AG is committed to delivering comprehensive healthcare solutions, encompassing various specialties and treatment options. Their dedication to innovation, expertise, and a patient-centered approach has positioned Mediclin AG as a trusted name in the healthcare industry. Continually evolving and adapting to meet the changing needs of the society, Mediclin AG remains dedicated to improving the overall well-being of individuals by delivering exceptional medical care.

Who are the main competitors of Mediclin in the market?

The main competitors of Mediclin AG in the market include big players like Fresenius SE & Co. KGaA, RHÖN-KLINIKUM AG, and Asklepios Kliniken GmbH & Co. KGaA.

In which industries is Mediclin primarily active?

Mediclin AG is primarily active in the healthcare industry.

What is the business model of Mediclin?

The business model of Mediclin AG, a leading healthcare provider, revolves around offering a diverse range of medical services and high-quality patient care. With a focus on providing acute care, rehabilitation, and post-acute care, Mediclin AG operates a network of clinics and hospitals across Germany. Its services include specialized medical treatments, innovative therapies, and comprehensive aftercare programs. By constantly striving for medical excellence and employing experienced healthcare professionals, Mediclin AG aims to deliver optimal outcomes for patients. This company's commitment to delivering superior healthcare services has made it a trusted and reliable choice for individuals seeking top-notch medical care in Germany.

What is the P/E ratio of Mediclin 2024?

The Mediclin P/E ratio is 8.28.

What is the P/S ratio of Mediclin 2024?

The Mediclin P/S ratio is 0.15.

What is the AlleAktien quality score of Mediclin?

The AlleAktien quality score for Mediclin is 2/10.

What is the revenue of Mediclin 2024?

The expected Mediclin revenue is 733.66 M EUR.

How high is the profit of Mediclin 2024?

The expected Mediclin profit is 13.19 M EUR.

What is the business model of Mediclin

The Mediclin AG is a company in the healthcare sector that offers various services. The company's headquarters is located in Offenburg and it has clinics, rehabilitation facilities, and nursing homes throughout Germany. The company's divisions include acute hospitals, rehabilitation, post-acute medicine, nursing, and outpatient care. Acute hospitals treat patients with acute illnesses and injuries. The rehabilitation and post-acute medicine departments specialize in helping patients recover after accidents or surgeries. The nursing departments are responsible for caring for older or dependent people. The outpatient services offer various medical services that are provided outside of a hospital setting. Among the products offered by the company are check-up programs in which patients are examined for their health condition. In addition, the company also offers various weight reduction and personal development programs. Additionally, the company offers a variety of therapy services such as physiotherapy, occupational therapy, and speech therapy. The goal of Mediclin AG is to be a holistic healthcare provider that helps people stay healthy and fit on all levels. This means that the company not only offers medical services, but also is active on a psychological and social level. Another business field of the company is research and development. Mediclin AG is involved in various research projects aimed at improving medical care. The company works closely with universities and other research institutes to develop new and innovative methods and technologies. Mediclin AG is a listed company and is listed on the Frankfurt Stock Exchange. The company has a solid financial structure and is able to invest in growth and innovation to increase its competitiveness. Overall, Mediclin AG offers a variety of medical services and products to help people lead healthier lives on many levels. The company follows a comprehensive strategy that ranges from research and development to patient care and is continuously focused on innovation and renewal. Mediclin AG strives to be a reliable and trustworthy partner to its customers in their search for health and well-being.

What is the Mediclin dividend?

Mediclin pays a dividend of 0 EUR distributed over payouts per year.

How often does Mediclin pay dividends?

The dividend cannot currently be calculated for Mediclin or the company does not pay out a dividend.

What is the Mediclin ISIN?

The ISIN of Mediclin is DE0006595101.

What is the Mediclin WKN?

The WKN of Mediclin is 659510.

What is the Mediclin ticker?

The ticker of Mediclin is MED.DE.

How much dividend does Mediclin pay?

Over the past 12 months, Mediclin paid a dividend of 0.05 EUR . This corresponds to a dividend yield of about 2.17 %. For the coming 12 months, Mediclin is expected to pay a dividend of 0 EUR.

What is the dividend yield of Mediclin?

The current dividend yield of Mediclin is 2.17 %.

When does Mediclin pay dividends?

Mediclin pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Mediclin?

Mediclin paid dividends every year for the past 3 years.

What is the dividend of Mediclin?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mediclin located?

Mediclin is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mediclin kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mediclin from 6/3/2019 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 5/30/2019.

When did Mediclin pay the last dividend?

The last dividend was paid out on 6/3/2019.

What was the dividend of Mediclin in the year 2023?

In the year 2023, Mediclin distributed 0 EUR as dividends.

In which currency does Mediclin pay out the dividend?

The dividends of Mediclin are distributed in EUR.

All fundamentals about Mediclin

Our stock analysis for Mediclin Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediclin Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.